October 9 2020
In current clinical practices, digital pathology technology has been instrumental. In the background of the latest Coronavirus outbreak, it has become more important resource in the research laboratory ecosystems and is gaining traction recently. Although it was initially created as a cost-effective pathological method to help pathologies achieve better efficiency, digital pathology is now reemerging as a key item for pathologies to present extended workflows in the global pandemic. Including emerging technologies as artificial intelligence (AI) and machine learning, the unprecedented advantages of digital pathology integration provide incredible diagnostic possibilities far beyond traditional cardiology, and radiation. The COVID-19 crisis immediately led to a rising demand for digital pathology, and the pathology industry’s fate may forever be changed.
Download FREE Sample Report: To Know the Impact of COVID-19 on this Industry@ https://www.databridgemarketresearch.com/covid-19-resources/covid-19-impact-on-digital-pathology-in-the-healthcare-industry
Global Digital Pathology Market, By Type (Human Pathology, Veterinary Pathology), Product (Scanners, Software, Communication Systems, Storage Systems), Application (Drug Discovery, Disease Diagnosis, Teleconsultation, Training & Education), End Users (Pharmaceutical & Biotechnology, Hospitals, Academic Research Institutes), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027.
Digital pathology market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 1,460.83 million by 2027 growing at a CAGR of 13.25% in the above-mentioned forecast period. The rising prevalence of cancer diseases is going to help in driving the growth of the digital pathology market.
The rising adoption of digital pathology to enhance lab efficiency and growing applications of digital pathology in drug development and companion diagnostics is likely to accelerate the growth of the digital pathology market in the forecast period of 2020-2027. On the other hand, introduction of growing demand of personalized medicine and affordable scanners for private pathology practices will further boost various opportunities that will lead to the growth of the digital pathology market in the above mentioned forecast period.
Global Anatomic Pathology Market By Product & Service (Instrument, Consumables, Antibodies, Others), End User (Pathology Labs, Research Institutes, Hospitals, Others), Application (Disease Diagnosis, Drug Discovery & Development, Other Applications), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026
Global Anatomic Pathology Market is expected to rise from its initial estimated value of USD 18.66 billion in 2018 to an estimated value of USD 30.53 billion by 2026, registering a CAGR of 6.35% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing Incidence of Cancer.
COVID-19 creates a great need for the remote working of pathologists which leads to a prolific demand for digital pathologies. The future development of digital pathology environments is further complemented by recent regulatory developments.
Anatomic pathology is a medical speciality that is required in the diagnosis of disease based on the microscopic, macroscopic, biochemical, immunologic and molecular examination of organs and tissues. In the last few years, surgical pathology has evolved extremely, from an ancient examination of whole bodies (autopsy) to modern techniques needed for the diagnosis and prognosis of cancer to guide treatment decision-making in oncology.
Digital Pathology, which records high-resolution tissue specimen images, was essential for the preservation of surgeries by pathologists during the pandemic. Such visual images can be viewed whenever possible and are easily exchanged in secondary opinions and views, or online, by overcoming the limitations of working with glass dispositive and microscopes.
The growing need for remote operations strongly drives this market for digital pathology. Importantly, a key regulatory development is also being accelerated. The demand for digital pathology has thus risen from both commercial and academic laboratories. Health centers have adopted the technology to promote joint training sessions and access to expertise. Many medical schools have already migrated online and now deliver a similar, if not the same, experience as students in the classroom.